Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
+$446M |
| 2 |
NVIDIA
NVDA
|
+$375M |
| 3 |
Apple
AAPL
|
+$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$317M |
| 5 |
Meta Platforms (Facebook)
META
|
+$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
Exxon Mobil
XOM
|
+$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
SoFi Technologies
SOFI
|
+$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DADA
3101
DELISTED
Dada Nexus
DADA
| $316K | ﹤0.01% |
260,522
+97,817
| +60% | +$119K |
|
3102
OptimumBank Holdings
OPHC
$50.1M
| $315K | ﹤0.01% |
66,086
+2,611
| +4% | +$12.4K |
|
3103
Larimar Therapeutics
LRMR
$331M
| $314K | ﹤0.01% |
81,150
-25,753
| -24% | -$99.7K |
|
|
BRAG
3104
Bragg Gaming Group
BRAG
$66.7M
| $307K | ﹤0.01% |
82,944
+10,838
| +15% | +$40.1K |
|
|
FORTY
3105
Formula Systems
FORTY
$2.15B
| $305K | ﹤0.01% |
3,638
-321
| -8% | -$26.9K |
|
3106
Live Ventures
LIVE
$53.4M
| $299K | ﹤0.01% |
32,036
| – | – |
|
|
SELF
3107
Global Self Storage
SELF
$58.3M
| $298K | ﹤0.01% |
55,866
| – | – |
|
3108
Cardiff Oncology
CRDF
$142M
| $297K | ﹤0.01% |
68,479
| – | – |
|
3109
XBiotech
XBIT
$85.1M
| $297K | ﹤0.01% |
75,135
+2,660
| +4% | +$10.5K |
|
|
CMLS
3110
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $297K | ﹤0.01% |
454,206
-83,824
| -16% | -$54.7K |
|
3111
Clover Health Investments
CLOV
$1.48B
| $297K | ﹤0.01% |
94,128
| – | – |
|
3112
Scholar Rock
SRRK
$3.04B
| $296K | ﹤0.01% |
6,839
-241,897
| -97% | -$10.5M |
|
3113
Seer Inc
SEER
$114M
| $295K | ﹤0.01% |
127,711
+5,000
| +4% | +$11.5K |
|
3114
Urban One Class A
UONE
$68.5M
| $295K | ﹤0.01% |
191,288
-20,889
| -10% | -$32.2K |
|
3115
Clear Channel Outdoor Holdings
CCO
$666M
| $293K | ﹤0.01% |
213,997
| – | – |
|
3116
Telus
TU
$25B
| $292K | ﹤0.01% |
21,529
-289
| -1% | -$3.92K |
|
3117
Werewolf Therapeutics
HOWL
$62.6M
| $288K | ﹤0.01% |
194,746
-63,098
| -24% | -$93.4K |
|
3118
Rigel Pharmaceuticals
RIGL
$644M
| $288K | ﹤0.01% |
+17,123
| New | +$288K |
|
3119
Leap Therapeutics
LPTX
$11.7M
| $288K | ﹤0.01% |
100,170
+18,707
| +23% | +$53.8K |
|
3120
Oramed Pharmaceuticals
ORMP
$94.7M
| $288K | ﹤0.01% |
118,995
+70,190
| +144% | +$170K |
|
3121
Avalon Holdings
AWX
$9.59M
| $288K | ﹤0.01% |
74,366
| – | – |
|
|
TOUR
3122
Tuniu
TOUR
$106M
| $287K | ﹤0.01% |
279,361
| – | – |
|
3123
NetSol Technologies
NTWK
$50.2M
| $286K | ﹤0.01% |
109,247
+4,199
| +4% | +$11K |
|
|
ACCS
3124
ACCESS Newswire Inc.
ACCS
$40.7M
| $279K | ﹤0.01% |
31,226
| – | – |
|
3125
Comstock Holding Companies
CHCI
$165M
| $272K | ﹤0.01% |
34,042
+1,888
| +6% | +$15.1K |
|